Award

MH116046

Funder: National Institute of Mental Health

Funded outputs count: 12

Funder award ID: MH116046

OpenAlex ID: G5008961823

Comparative Mortality Risk of Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Alzheimer’s Disease: A Real‑World Retrospective Cohort Study with Treatment Effect Heterogeneity Analysis

2026 · Chen Jiang, Josh Krivinko, et al. · CNS Drugs

Comparative Mortality Risk of Aripiprazole, Olanzapine, Quetiapine and Risperidone in Alzheimer’s Disease: A Real□World Cohort Study with Treatment Effect Heterogeneity Analysis

2025 · Chen Jiang, Josh Krivinko, et al. · medRxiv

Oligodendrocyte myelin glycoprotein impairs dendritic arbors via schizophrenia risk gene Trio

2025 · Euan Parnell, Jessica M. Christiansen, et al. · Neurobiology of Disease · 1

Exploring Potential Medications for Alzheimer’s Disease with Psychosis by Integrating Drug Target Information into Deep Learning Models: A Data-Driven Approach

2025 · Oshin Miranda, Chen Jiang, et al. · International Journal of Molecular Sciences · 3

A brain DNA co‐methylation network analysis of psychosis in Alzheimer's disease

2025 · Morteza Kouhsar, Luke Weymouth, et al. · Alzheimer s & Dementia · 6

Differential regulation of MAP2 by phosphorylation events in proline‐rich versus C‐terminal domains

2023 · R. A. DeGiosio, P. G. Needham, et al. · The FASEB Journal · 8

Unveiling the Enigma: Exploring Risk Factors and Mechanisms for Psychotic Symptoms in Alzheimer’s Disease through Electronic Medical Records with Deep Learning Models

2023 · Peihao Fan, Oshin Miranda, et al. · Pharmaceuticals · 14

More than a marker: potential pathogenic functions of MAP2

2022 · Rebecca A. DeGiosio, Melanie J. Grubisha, et al. · Frontiers in Molecular Neuroscience · 162

Schizophrenia-associated differential DNA methylation in brain is distributed across the genome and annotated to MAD1L1, a locus at which DNA methylation and transcription phenotypes share genetic variation with schizophrenia risk

2022 · Brandon C. McKinney, Lora L. McClain, et al. · Translational Psychiatry · 29

Psychosis in Alzheimer's Disease Is Associated With Increased Excitatory Neuron Vulnerability and Post-transcriptional Mechanisms Altering Synaptic Protein Levels

2022 · MR DeChellis-Marks, Y Wei, et al. · Frontiers in Neurology · 13

Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease

2021 · Mary Ann A. DeMichele-Sweet, Lambertus Klei, et al. · Molecular Psychiatry · 64

Hippocampal sclerosis, TDP‐43, and the duration of the symptoms of dementia of AD patients

2020 · Oscar L. Lopez, Julia Kofler, et al. · Annals of Clinical and Translational Neurology · 28